17.08.2017 • NewsElaine BurridgeIndorama VenturesIVL

Indorama Buys DuraFiber’s Mexican Assets

(c) cacaroot/Fotolia
(c) cacaroot/Fotolia

Indorama Ventures (IVL), the world’s leading PET producer, is to acquire the Mexican operations of US durable technical textiles maker DuraFiber Technology for an undisclosed sum. The transaction will be undertaken by IVL subsidiary Indorama Netherlands and is expected to close in the fourth quarter of 2017, subject to regulatory approvals.

DuraFiber’s plant in Queretaro, Mexico, is co-sited with IVL Mexico and can produce 37,500 t/y of high modulus low shrinkage PET, heavy denier industrial PET and nylon 6 for use in tire cord and  industrial textiles.

IVL’s CEO, Aloke Lohia, said: “The acquisition of DuraFiber will align with IVL’s strategy of pursuing accretive growth opportunities in the high value-added segment and complements the current tire cord fabric products. The combination of a strong local company with recognized products and deep insights into the market with IVL’s global scale will enable IVL to better meet customers’ evolving needs.”

At the same time, IVL has agreed to acquire DuraFiber Longlaville in France, which has capacity to produce 35,000 t/y of tire cord yarns. IVL said it would make an additional announcement on this transaction as soon as a definitive share purchase agreement is concluded. 

In April, the Thai producer agreed to buy Austria’s Glanzstoff Group, which produces tire cord fabrics and single-end cords at three plants in Luxembourg, Italy and the Czech Republic.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.